Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Bishara, L. Ore, N. Armaly, D. Weiler Ravell (Nazareth, , Haifa, Israel). High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel. Eur Respir J 2012; 40: Suppl. 56, 2652

Member's Comments

No comment yet.

Related content which might interest you: A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland Source: Eur Respir J 2005; 26: Suppl. 49, 425s Year: 2005 Latent tuberculosis infection (LTBI) treatment completion and complication in Leeds, UK Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Tuberculin skin test (TST) conversions rates, its relationship with interferon gamma release assay and safety and efficacy of 4 months rifampicin therapy (4R) for latent TB infection (LTBI) among nursing students in south India Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010 An audit of diagnosis and chemoprophylaxis treatment of latent tuberculosis Infection (LTBI) in TB contact patients in a district general hospital (DGH) in the United Kingdom (UK) Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel Source: Eur Respir J 2008; 32: 413-418 Year: 2008 High rate of hepatitis due to treatment with pyrazinamide (PYR) and ethambutol (EMB) for latent tuberculosis infection (LTBI) in subjects exposed to MDR-TB Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005 Latent tuberculosis infection (LTBI) detected by whole blood interferon gamma based assay among health care workers (HCW) in Poland Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Incidence of TB latent infection in health care workers in a low TB prevalence country Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 TB detection in children in Moscow (Russia) as in low TB incidence region Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Acceptance, and compliance to treatment for latent tuberculous infection (LTBI) in Geneva (1993-2002) Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005 Treatment of latent tuberculosis in immigrants from Somalia: Case-monitoring and adherence Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI) Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 The sarcoidosis-tuberculosis (TB) link: molecular evidence from a high (TB) prevalence country Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009